CanaQuest Medical Corp
CanaQuest Medical Corp is a life science company focused on medical cannabis products. The Company is committed to developing novel health products that utilize cannabis, hemp, and botanical extracts, including algae oils.
The Company has engaged two prestigious Canadian universities to research and develop formulated products, which the company is in the process of launching. Our research is focused on the use of cannabis in the context of cancer and the use of cannabis derivatives for the development of our novel pharmacotherapies for mental health, such as anxiety, depression, addiction, schizophrenia, and Post Traumatic Stress Disorder “PTSD”. CanaQuest was awarded a cannabis sales-import-export license from Health Canada.
Additionally, CanaQuest filed an international patent on a game-changing discovery, Mentabinol™, protecting THC users from negative psychiatric side-effects. Recently the Company won the Go Global Awards “Business of the Year – Category of Life Science”, presented by the International Trade Council.